3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Effectiveness and cost-effectiveness of a transdiagnostic intervention for alcohol misuse and psychological distress in humanitarian settings: study protocol for a randomised controlled trial in Uganda

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The war in South Sudan has displaced more than four million people, with Uganda hosting the largest number of South Sudanese refugees. Research in Uganda has shown elevated levels of alcohol misuse and psychological distress among these refugees. The World Health Organization (WHO) has developed a trans-diagnostic scalable psychological intervention called Problem Management Plus (PM +) to reduce psychological distress among populations exposed to adversities. Our study aims to evaluate the effectiveness and cost-effectiveness of the CHANGE intervention, which builds on PM + , to also address alcohol misuse through problem-solving therapy and selected behavioural strategies for dealing with alcohol use disorders. We hypothesise that the CHANGE intervention together with enhanced usual care (EUC) will be superior to EUC alone in increasing the percentage of days abstinent.

          Methods

          A parallel-arm individually randomised controlled trial will be conducted in the Rhino Camp and Imvepi settlements in Uganda. Five hundred adult male South Sudanese refugees with (i) elevated levels of alcohol use (between 8 and 20 on the Alcohol Use Disorder Identification Test [AUDIT]); and (ii) psychological distress (> 16 on the Kessler Psychological Distress Scale) will be randomly assigned 1:1 to EUC or CHANGE and EUC. CHANGE will be delivered by lay healthcare providers over 6 weeks. Outcomes will be assessed at 3 and 12 months post-randomisation. The primary outcome is the percentage of days abstinent, measured by the timeline follow-back measure at 3 months. Secondary outcomes include percentage of days abstinent at 12 months and alcohol misuse (measured by the AUDIT), psychological distress (i.e. depression, anxiety, posttraumatic stress disorder), functional disability, perpetration of intimate partner violence, and health economic indicators at 3 and 12 months. A mixed-methods process evaluation will investigate competency, dose, fidelity, feasibility, and acceptability. Primary analyses will be intention-to-treat.

          Discussion

          CHANGE aims to address alcohol misuse and psychological distress with male refugees in a humanitarian setting. If it is proven to be effective, it can help fill an important under-researched gap in humanitarian service delivery.

          Trial registration

          ISRCTN ISRCTN10360385. Registered on 30 January 2023.

          Related collections

          Most cited references42

          • Record: found
          • Abstract: found
          • Article: not found

          Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)

          Purpose This article introduces the new 5-level EQ-5D (EQ-5D-5L) health status measure. Methods EQ-5D currently measures health using three levels of severity in five dimensions. A EuroQol Group task force was established to find ways of improving the instrument’s sensitivity and reducing ceiling effects by increasing the number of severity levels. The study was performed in the United Kingdom and Spain. Severity labels for 5 levels in each dimension were identified using response scaling. Focus groups were used to investigate the face and content validity of the new versions, including hypothetical health states generated from those versions. Results Selecting labels at approximately the 25th, 50th, and 75th centiles produced two alternative 5-level versions. Focus group work showed a slight preference for the wording ‘slight-moderate-severe’ problems, with anchors of ‘no problems’ and ‘unable to do’ in the EQ-5D functional dimensions. Similar wording was used in the Pain/Discomfort and Anxiety/Depression dimensions. Hypothetical health states were well understood though participants stressed the need for the internal coherence of health states. Conclusions A 5-level version of the EQ-5D has been developed by the EuroQol Group. Further testing is required to determine whether the new version improves sensitivity and reduces ceiling effects.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Short screening scales to monitor population prevalences and trends in non-specific psychological distress

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              The PHQ-9: A New Depression Diagnostic and Severity Measure

                Bookmark

                Author and article information

                Contributors
                catharina.van-der-boor@lshtm.ac.uk
                Journal
                Trials
                Trials
                Trials
                BioMed Central (London )
                1745-6215
                27 February 2024
                27 February 2024
                2024
                : 25
                : 148
                Affiliations
                [1 ]Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, ( https://ror.org/00a0jsq62) 15-17 Tavistock Place, London, WC1H 9SH UK
                [2 ]HealthRight International, Plot 855, Mawanda Road -Kamwokya, Kampala, Uganda
                [3 ]MRC International Statistics and Epidemiology Group, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, ( https://ror.org/00a0jsq62) Keppel Street, London, WC1E 7HT UK
                [4 ]MRC/UVRI Uganda Research Unit, London School of Hygiene and Tropical Medicine, ( https://ror.org/00a0jsq62) Plot 51-59 Nakiwogo Road, PO Box 49, Entebbe, Uganda
                [5 ]Department of Public Health, University of Copenhagen, ( https://ror.org/035b05819) Bartholinsgade 4, Bg. 9, 1356 København K, CSS, Bg. 9, Building: 9.2.16, Copenhagen, Denmark
                [6 ]Department of Prevention and Evaluation, Leibniz Institute for Prevention Research and Epidemiology, ( https://ror.org/02c22vc57) Achterstraße 30, 28359 Bremen, Germany
                [7 ]Health Sciences, University of Bremen, ( https://ror.org/04ers2y35) Bremen, Germany
                [8 ]Centre for Global Mental Health (CGMH), Department of Population Health, London School of Hygiene & Tropical Medicine, ( https://ror.org/00a0jsq62) London, UK
                [9 ]Addictions Research Group, ( https://ror.org/00y3z1g83) Sangath, Goa India
                Author information
                http://orcid.org/0000-0003-2710-7601
                Article
                7980
                10.1186/s13063-024-07980-7
                10900822
                38414078
                e3f85738-638c-41c3-b11e-e3220abbf98e
                © The Author(s) 2024

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 14 November 2023
                : 12 February 2024
                Funding
                Funded by: NIHR and Wellcome Trust
                Award ID: 219468/Z/19/Z
                Award Recipient :
                Categories
                Study Protocol
                Custom metadata
                © BioMed Central Ltd., part of Springer Nature 2024

                Medicine
                refugees,alcohol misuse,mental distress,scalable interventions,randomised controlled trial

                Comments

                Comment on this article